INTERSPECIES DIFFERENCES IN INVITRO ETOPOSIDE PLASMA-PROTEIN BINDING

被引：10
作者：
FLEMING, RA
ARBUCK, SG
STEWART, CF
机构：
[1] UNIV TENNESSEE CTR HLTH SCI,COLL PHARM,DEPT CLIN PHARM,MEMPHIS,TN 38163
[2] SUNY BUFFALO,BUFFALO,NY 14260
来源：
BIOCHEMICAL PHARMACOLOGY | 1991年 / 42卷 / 11期
关键词：
D O I：
10.1016/0006-2952(91)90364-B
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：2246 / 2249
页数：4
相关论文
共 22 条
[1]  
ANDRESS L, 1988, PHARMACEUT RES, V5, pS215
[2]   THE EFFECT OF ETOPOSIDE ON HUMAN CFU-GM [J].
BAILEYWOOD, R ;
DALLIMORE, CM ;
LITTLEWOOD, TJ ;
BENTLEY, DP .
BRITISH JOURNAL OF CANCER, 1985, 52 (04) :613-617
[3]   IMPORTANCE OF RADIOCHEMICAL PURITY OF RADIOLABELED DRUGS USED FOR DETERMINING PLASMA-PROTEIN BINDING OF DRUGS [J].
BJORNSSON, TD ;
BROWN, JE ;
TSCHANZ, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (12) :1372-1373
[4]   SPECIES DIFFERENCES IN BINDING OF PHENYLBUTAZONE TO PLASMA ALBUMIN [J].
CHIGNELL, CF ;
STARKWEATHER, DK .
PHARMACOLOGY, 1971, 5 (04) :235-+
[5]  
COLLINS JM, 1986, CANCER TREAT REP, V70, P73
[6]   PHARMACOLOGICALLY GUIDED PHASE-I CLINICAL-TRIALS BASED UPON PRECLINICAL DRUG DEVELOPMENT [J].
COLLINS, JM ;
GRIESHABER, CK ;
CHABNER, BA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16) :1321-1326
[7]  
FLEMING RA, 1989, CLIN PHARMACY, V8, P274
[8]  
FLEMING RA, IN PRESS J PHARM SCI
[9]  
FOX JG, 1984, LABORATORY ANIMAL ME
[10]  
FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219
123